← Leaderboards
Alex Jordan Harvey
Synageva Biopharma Corporation
$1,714,526
Attributed
$1,714,526
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.4K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,714,526 · 5
By mechanism
R43$968,262 · 4
R44$746,264 · 1
Top collaborators
No co-investigators on record.
Most similar at Synageva Biopharma Corporation
Same institution · by research overlap
- Mark C. Leavitt$1,556,851
- Leandro Christmann$623,937
- Stephen H Parker$91,727
Others in their field
Top investigators on “Chickens”
- Cheng-Ming Chuong · University Of Southern California$16,254,367
- David C Page · Whitehead Institute For Biomedical Res$12,930,312
- Olivier Pourquie · Stowers Institute For Medical Research$12,828,055
- Sayera Banu · International Ctr/Diarrhoeal Dis Res$12,004,580
- Marianne Bronner-Fraser · California Institute Of Technology$11,122,510
- Parker B Antin · University Of Arizona$10,392,039
Research focus
ChickensGenerationsGlycosylationProteinsMalignant NeoplasmsPeptidesPolyclonal AntibodyAntigensElementsEpitopesLinkBaseMonoclonal AntibodiesOryctolagus CuniculusAntibodiesCarbohydratesAnimalsCharacteristicsCellsBiotechnologyAffinityEnzymesComplexGlycopeptides
Grant awards (7)
Targeting aberrant glycopeptide tumor antigens for generation of novel cancer therapeutics with enhanced selectivity and utility$212,853
R43 · FY2018 · GM · contact PI
Targeting aberrant glycopeptide tumor antigens for generation of novel cancer therapeutics with enhanced selectivity and utility$223,217
R43 · FY2017 · GM · contact PI
Antibodies to O-GlcNAc modified histones for chromatin biology and epigenetic res$349,180
R43 · FY2014 · GM · contact PI
Enhancement of the glycosylation machinery of the hen bioreactor.$93,012
R43 · FY2008 · GM · contact PI
Avian transgenesis via site-directed integration$336,837
R44 · FY2006 · GM · contact PI
Avian transgenesis via site-directed integration$409,427
R44 · FY2005 · GM
Avian transgenesis via site-directed integration$90,000
R43 · FY2004 · GM